Cargando…
How glycobiology can help us treat and beat the COVID-19 pandemic
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged during the last months of 2019, spreading throughout the world as a highly transmissible infectious illness designated as COVID-19. Vaccines have now appeared, but the challenges in producing sufficient material and distributing th...
Autores principales: | Lardone, Ricardo D., Garay, Yohana C., Parodi, Pedro, de la Fuente, Sofia, Angeloni, Genaro, Bravo, Eduardo O., Schmider, Anneke K., Irazoqui, Fernando J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857991/ https://www.ncbi.nlm.nih.gov/pubmed/33548227 http://dx.doi.org/10.1016/j.jbc.2021.100375 |
Ejemplares similares
-
A perspective on the PDB’s impact on the field of glycobiology
por: Prestegard, James H.
Publicado: (2021) -
Purified human anti-Tn and anti-T antibodies specifically recognize carcinoma tissues
por: Zlocowski, Natacha, et al.
Publicado: (2019) -
A Chicken Tapasin ortholog can chaperone empty HLA-B∗37:01 molecules independent of other peptide-loading components
por: Papadaki, Georgia F., et al.
Publicado: (2023) -
Molecular glycobiology /
Publicado: (1994) -
Lectins and Glycobiology
Publicado: (1993)